Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of ROTEM-based Coagulation Surveillance on Reducing Blood Product Utilization During Complex Spine Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \> 18 and \< 80 years old.~2. Elective spine surgery cases, with a traditional open posterior approach and involving fusion of at least 5 levels.~3. Normal coagulation profile (PT/INR, aPTT) and normal platelets count on pre-operative evaluation.~4. Preoperative hemoglobin Level \>10 g/dl.~5. OR time \> 4 hours.~6. No contraindication for the use of anti-fibrinolytic therapy (Tranexamic acid).~Exclusion Criteria:~1. Age \< 18 or age \> 80 years old.~2. Anterior spine surgeries or posterior spine surgeries involving \<5 levels.~3. Minimally invasive spine surgeries.~4. Patients with known coagulopathies or bleeding tendencies or patients with abnormal coagulation laboratory values at baseline.~5. Patients with Hemoglobin level of \<10 g/dl on preoperative baseline laboratory values.~6. Trauma and Emergency spine surgeries.~7. Patients with spine malignancy diagnosis, either primary or metastatic.~8. OR time \< 4 hours.~9. Patients who refuse to use allogenic blood products.~10. Patients with contraindications for the use of anti-fibrinolytic therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- ROTEM Group (Type: EXPERIMENTAL): Patients who are randomized to receive ROTEM
- Control Group (Type: OTHER): Patients who are randomized not to receive ROTEM

Based on this trial design, predict the completion outcome and termination type (if applicable).